Inside the research
Covista Inc.
CVSA Research profile · latest available data
Price overview
$120.75
▼ -3.41 (-2.7%)
| 52w hi | $154.45 |
|---|---|
| 52w lo | $89.36 |
| Vol | 525.90K |
| As of | 25 Sep 2026 |
The Verdict
Our score -0.01
| Short | -0.32 |
|---|---|
| Medium | +0.09 |
| Long | +0.39 |
computed 2026-09-27
Key fundamentals
Covista Inc.
Consumer Defensive · Education & Training Services
| Market cap | $4.11B |
|---|---|
| Enterprise value | $4.61B |
| Trailing P/E | 16.12x |
| Forward P/E | 12.07x |
| EV / EBITDA | 10.36x |
| P / S (ttm) | 2.10x |
| Profit margin | 12.9% |
| Return on equity | 18.6% |
| Revenue growth | +9.7% |
| Earnings growth | +43.2% |
| Debt / equity | 62.61 |
Layer Breakdown
| Layer | Raw | Contribution |
|---|---|---|
| Fundamental | +0.38 | |
| Sector | -0.01 | |
| Technical | +0.13 | |
| Earnings | +0.00 | |
| Sentiment | -0.58 |
macro × 1.00 · 2026-09-27
Business overview
Covista Inc., together with its subsidiaries, provides healthcare education in the United States, Barbados, St. Kitts, and St. Maarten. It operates in three segments: Chamberlain, Walden, and Medical and Veterinary. The company provides degree programs, including bachelor's, master's, and doctoral degrees; and online certificate programs for nursing, health professions, medical, and veterinary postsecondary education, counseling, business, information technology, psychology, public health, social work and human services, public administration and public policy, and criminal justice. It also operates Chamberlain University, Walden University, American University of the Caribbean School of Medicine, Ross University School of Medicine, and Ross University School of Veterinary Medicine. The company was formerly known as Adtalem Global Education Inc. and changed its name to Covista Inc. in February 2026. Covista Inc. was incorporated in 1987 and is headquartered in Chicago, Illinois.
Risk Metrics
| Beta vs SPX | 0.66 |
|---|---|
| Corr SPX | 0.23 |
| Annual vol | 46.9% |
| Annual ret | +35.1% |
| Sharpe | 0.75 |
| Max DD | -42.1% |
Window: 504 trading days (504 obs)
Material Events
| Date | Event | 8-K |
|---|---|---|
| 2026-08-06 | Earnings Release, Exhibits | read |
| 2026-07-28 | Officer / Director Change, Exhibits | read |
| 2026-05-07 | Earnings Release, Exhibits | read |
| 2026-04-09 | Reg FD Disclosure, Exhibits | read |
| 2026-03-03 | Material Agreement, Termination of Agreement… | read |
| 2026-02-24 | Reg FD Disclosure, Exhibits | read |
| 2026-02-06 | Bylaws Amendment, Reg FD Disclosure… | read |
| 2026-01-28 | Earnings Release, Exhibits | read |
| 2025-12-15 | Other Material Event, Exhibits | read |
| 2025-11-14 | Shareholder Vote | read |
| 2025-10-30 | Earnings Release, Exhibits | read |
| 2025-10-07 | Other Material Event, Exhibits | read |
Insider Trades
| Date | Insider | Role | Action | Shares | Value |
|---|---|---|---|---|---|
| 2026-08-11 | Beard, Stephen W. | Chairman & CEO | Sell | 3.54K | $462.07K |
| 2026-08-07 | Phelan Robert J. | Chief Financial Officer | Sell | 2.19K | $295.44K |
| 2026-08-07 | BECK DOUGLAS G. | SVP, GC, Corp. Sec & ISS | Sell | 4.53K | $614.68K |
| 2026-07-15 | Manning Amelia | President, Chamberlain Un | Grant | 4.32K | $499.99K |
| 2026-07-13 | Beard, Stephen W. | Chairman & CEO | Sell | 5.29K | $702.40K |
| 2026-07-08 | Phelan Robert J. | Chief Financial Officer | Sell | 2.41K | $326.82K |
| 2026-07-08 | BECK DOUGLAS G. | SVP, GC, Corp. Sec & ISS | Sell | 2.44K | $330.09K |
| 2026-07-07 | BECK DOUGLAS G. | SVP, GC, Corp. Sec & ISS | Sell | 2.65K | $358.82K |
| 2026-07-07 | Phelan Robert J. | Chief Financial Officer | Sell | 2.90K | $392.68K |
| 2026-06-11 | Beard, Stephen W. | Chairman & CEO | Sell | 2.53K | $330.75K |
Flow & Concentration
| Insider 180d net | -$5.44M |
|---|---|
| Insider buys / sells | 0 / 11 |
| Insider bias | Sellers |
| 13F holders | 9 |
| Top-5 share | 98.8% |
| HHI | 4,786 (concentrated) |
Top Holders
| Holder | Value | Shares |
|---|---|---|
| Fidelity / FMR LLC | $401.18M | 3.22M |
| State Street Corp | $173.21M | 1.39M |
| AQR Capital Management | $33.38M | 271.95K |
| Millennium Management | $9.67M | 77.58K |
| Capital Research / Capital World | $8.53M | 68.44K |
| Citadel Advisors | $2.80M | 22.50K |
| Renaissance Technologies | $2.72M | 21.80K |
| Bridgewater Associates | $2.14M | 17.15K |
| T. Rowe Price Group | $95.73K | 767.93K |
As of 2026-06-30
Dividends
| Yield (TTM) | 0.00% |
|---|---|
| $ / share (TTM) | $0.00 |
| 5y CAGR | +5.9% |
Annual dividend per share
| 2011 | $0.27 |
|---|---|
| 2012 | $0.32 |
| 2013 | $0.34 |
| 2014 | $0.35 |
| 2015 | $0.36 |
| 2016 | $0.36 |
SEC Filings
The Long Run
FY 2011–2025 · 15 years
| Line | Latest | CAGR | Trend |
|---|---|---|---|
| Revenue | $1.45B | -0.1% | |
| Operating income | $168.17M | -9.4% | |
| Net income | $93.36M | -4.7% | |
| Cash from ops | $337.90M | -1.3% |
Indices
Recent Sessions
| Date | Open | High | Low | Close | Vol |
|---|---|---|---|---|---|
| Sep 25 | $124.31 | $124.31 | $120.70 | $120.75 | 525.90K |
| Sep 24 | $123.80 | $125.89 | $122.73 | $124.16 | 407.30K |
| Sep 23 | $122.27 | $124.42 | $121.09 | $123.19 | 260.90K |
| Sep 22 | $127.00 | $127.20 | $122.14 | $123.00 | 428.10K |
| Sep 21 | $127.28 | $127.28 | $124.01 | $125.79 | 246.70K |
Understand the score. Research layers are inputs to a model, and the available data has limits.
Read the methodology →